| Sarah Brown, CRNA | |
|
9000 Franklin Square Dr, Baltimore, MD 21237-3901 | |
| (443) 777-7000 | |
| Not Available |
| Full Name | Sarah Brown |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 9000 Franklin Square Dr, Baltimore, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255502837 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R166780 (Maryland) | Primary |
| Entity Name | Johns Hopkins University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922008549 PECOS PAC ID: 8921903147 Enrollment ID: O20031215000719 |
News Archive
Researchers from the Washington University School Of Medicine have identified how a subset of variants of concern can escape neutralization by two neutralizing antibodies.
The House on Thursday voted 241-178 to approve a fiscal year 2008 foreign aid spending bill that would allow the federal government to give contraceptives but not money to international groups barred from receiving U.S. aid because of their abortion policies, the Washington Post reports (Williamson, Washington Post, 6/22).
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).
Takeda Pharmaceutical Company Limited and URL Pharma Inc. jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings, Inc. and URL Pharma have entered into a definitive agreement to acquire URL Pharma – a privately-held pharmaceutical company headquartered in Philadelphia, Pennsylvania, for an upfront payment of $800 million and future performance-based contingent earn out payments.
› Verified 6 days ago
| Entity Name | University Of Maryland Anesthesiology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720024235 PECOS PAC ID: 8022905306 Enrollment ID: O20040302000341 |
News Archive
Researchers from the Washington University School Of Medicine have identified how a subset of variants of concern can escape neutralization by two neutralizing antibodies.
The House on Thursday voted 241-178 to approve a fiscal year 2008 foreign aid spending bill that would allow the federal government to give contraceptives but not money to international groups barred from receiving U.S. aid because of their abortion policies, the Washington Post reports (Williamson, Washington Post, 6/22).
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).
Takeda Pharmaceutical Company Limited and URL Pharma Inc. jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings, Inc. and URL Pharma have entered into a definitive agreement to acquire URL Pharma – a privately-held pharmaceutical company headquartered in Philadelphia, Pennsylvania, for an upfront payment of $800 million and future performance-based contingent earn out payments.
› Verified 6 days ago
| Entity Name | University Of Maryland Medical System Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508807355 PECOS PAC ID: 7113914771 Enrollment ID: O20040427000918 |
News Archive
Researchers from the Washington University School Of Medicine have identified how a subset of variants of concern can escape neutralization by two neutralizing antibodies.
The House on Thursday voted 241-178 to approve a fiscal year 2008 foreign aid spending bill that would allow the federal government to give contraceptives but not money to international groups barred from receiving U.S. aid because of their abortion policies, the Washington Post reports (Williamson, Washington Post, 6/22).
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).
Takeda Pharmaceutical Company Limited and URL Pharma Inc. jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings, Inc. and URL Pharma have entered into a definitive agreement to acquire URL Pharma – a privately-held pharmaceutical company headquartered in Philadelphia, Pennsylvania, for an upfront payment of $800 million and future performance-based contingent earn out payments.
› Verified 6 days ago
| Entity Name | First Colonies Anesthesia Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740218767 PECOS PAC ID: 8426039744 Enrollment ID: O20040525000119 |
News Archive
Researchers from the Washington University School Of Medicine have identified how a subset of variants of concern can escape neutralization by two neutralizing antibodies.
The House on Thursday voted 241-178 to approve a fiscal year 2008 foreign aid spending bill that would allow the federal government to give contraceptives but not money to international groups barred from receiving U.S. aid because of their abortion policies, the Washington Post reports (Williamson, Washington Post, 6/22).
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).
Takeda Pharmaceutical Company Limited and URL Pharma Inc. jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings, Inc. and URL Pharma have entered into a definitive agreement to acquire URL Pharma – a privately-held pharmaceutical company headquartered in Philadelphia, Pennsylvania, for an upfront payment of $800 million and future performance-based contingent earn out payments.
› Verified 6 days ago
| Entity Name | Zinder Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518195296 PECOS PAC ID: 3072658400 Enrollment ID: O20100309000756 |
News Archive
Researchers from the Washington University School Of Medicine have identified how a subset of variants of concern can escape neutralization by two neutralizing antibodies.
The House on Thursday voted 241-178 to approve a fiscal year 2008 foreign aid spending bill that would allow the federal government to give contraceptives but not money to international groups barred from receiving U.S. aid because of their abortion policies, the Washington Post reports (Williamson, Washington Post, 6/22).
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).
Takeda Pharmaceutical Company Limited and URL Pharma Inc. jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings, Inc. and URL Pharma have entered into a definitive agreement to acquire URL Pharma – a privately-held pharmaceutical company headquartered in Philadelphia, Pennsylvania, for an upfront payment of $800 million and future performance-based contingent earn out payments.
› Verified 6 days ago
| Entity Name | Global Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013312412 PECOS PAC ID: 3173610466 Enrollment ID: O20150304000182 |
News Archive
Researchers from the Washington University School Of Medicine have identified how a subset of variants of concern can escape neutralization by two neutralizing antibodies.
The House on Thursday voted 241-178 to approve a fiscal year 2008 foreign aid spending bill that would allow the federal government to give contraceptives but not money to international groups barred from receiving U.S. aid because of their abortion policies, the Washington Post reports (Williamson, Washington Post, 6/22).
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).
Takeda Pharmaceutical Company Limited and URL Pharma Inc. jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings, Inc. and URL Pharma have entered into a definitive agreement to acquire URL Pharma – a privately-held pharmaceutical company headquartered in Philadelphia, Pennsylvania, for an upfront payment of $800 million and future performance-based contingent earn out payments.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Brown, CRNA 9000 Franklin Square Dr, Baltimore, MD 21237-3901 Ph: (443) 777-7000 | Sarah Brown, CRNA 9000 Franklin Square Dr, Baltimore, MD 21237-3901 Ph: (443) 777-7000 |
News Archive
Researchers from the Washington University School Of Medicine have identified how a subset of variants of concern can escape neutralization by two neutralizing antibodies.
The House on Thursday voted 241-178 to approve a fiscal year 2008 foreign aid spending bill that would allow the federal government to give contraceptives but not money to international groups barred from receiving U.S. aid because of their abortion policies, the Washington Post reports (Williamson, Washington Post, 6/22).
Morphotek(R), Inc., a subsidiary of Eisai Corporation of North America, today announced preliminary data from a Phase II trial evaluating the safety and efficacy of farletuzumab in platinum-sensitive epithelial ovarian cancer subjects experiencing their first relapse. Farletuzumab (MORAb-003) is a humanized monoclonal antibody that targets the Folate Receptor Alpha (FRA).
Takeda Pharmaceutical Company Limited and URL Pharma Inc. jointly announced that Takeda's wholly-owned subsidiary, Takeda America Holdings, Inc. and URL Pharma have entered into a definitive agreement to acquire URL Pharma – a privately-held pharmaceutical company headquartered in Philadelphia, Pennsylvania, for an upfront payment of $800 million and future performance-based contingent earn out payments.
› Verified 6 days ago
Ms. Jennifer Renee Pease Moreno, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: Jhu 600 N Wolfe St, Dept Anesthesia Critical Care Medicine- Blalock 14th Fl, Baltimore, MD 21287 Phone: 410-955-4552 | |
Kristen Marll, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2401 W Belvedere Ave, Baltimore, MD 21215 Phone: 410-601-5209 | |
Mrs. Victoria Volta Manger, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 900 S Caton Ave, Baltimore, MD 21229 Phone: 667-234-3045 | |
Duncan Mcelfresh, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2401 W Belvedere Ave, Anesthesia Department, Baltimore, MD 21215 Phone: 410-601-5209 Fax: 410-601-9744 | |
Mr. Michael W Hoban, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 301 Saint Paul St, Baltimore, MD 21202 Phone: 410-332-9375 | |
Mrs. Dama Reter Yekeson-koffa, RN, SRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 4940 Eastern Ave, Anesthesia Department Bayview Medical Center, Baltimore, MD 21224 Phone: 443-694-8960 Fax: 410-356-5821 | |
Kelly Mccarthy, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-8667 |